Abbott Laboratories Statistics

Total Valuation

LON:0Q15 has a market cap or net worth of GBP 175.26 billion. The enterprise value is 181.09 billion.

Market Cap	175.26B
Enterprise Value	181.09B

Important Dates

The next estimated earnings date is Wednesday, April 16, 2025.

Earnings Date	Apr 16, 2025
Ex-Dividend Date	Apr 15, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-0.06%
Shares Change (QoQ)	-0.09%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.72B

Valuation Ratios

The trailing PE ratio is 16.43.

PE Ratio	16.43
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	12.25
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 21.16, with an EV/FCF ratio of 35.70.

EV / Earnings	16.98
EV / Sales	5.59
EV / EBITDA	21.16
EV / EBIT	31.27
EV / FCF	35.70

Financial Position

The company has a current ratio of 1.67, with a Debt / Equity ratio of 0.32.

Current Ratio	1.67
Quick Ratio	1.05
Debt / Equity	0.32
Debt / EBITDA	1.38
Debt / FCF	2.41
Interest Coverage	13.41

Financial Efficiency

Return on equity (ROE) is 30.91% and return on invested capital (ROIC) is 7.95%.

Return on Equity (ROE)	30.91%
Return on Assets (ROA)	6.06%
Return on Invested Capital (ROIC)	7.95%
Return on Capital Employed (ROCE)	11.15%
Revenue Per Employee	293,933
Profits Per Employee	93,547
Employee Count	114,000
Asset Turnover	0.54
Inventory Turnover	2.92

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +15.84% in the last 52 weeks. The beta is 0.66, so LON:0Q15's price volatility has been lower than the market average.

Beta (5Y)	0.66
52-Week Price Change	+15.84%
50-Day Moving Average	129.56
200-Day Moving Average	116.35
Relative Strength Index (RSI)	53.92
Average Volume (20 Days)	17,075

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.21

Income Statement

In the last 12 months, LON:0Q15 had revenue of GBP 33.51 billion and earned 10.66 billion in profits. Earnings per share was 6.10.

Revenue	33.51B
Gross Profit	18.62B
Operating Income	5.99B
Pretax Income	5.60B
Net Income	10.66B
EBITDA	8.56B
EBIT	5.99B
Earnings Per Share (EPS)	6.10

Full Income Statement

Balance Sheet

The company has 6.36 billion in cash and 12.20 billion in debt, giving a net cash position of -5.84 billion.

Cash & Cash Equivalents	6.36B
Total Debt	12.20B
Net Cash	-5.84B
Net Cash Per Share	n/a
Equity (Book Value)	38.26B
Book Value Per Share	21.99
Working Capital	7.59B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 6.84 billion and capital expenditures -1.76 billion, giving a free cash flow of 5.07 billion.

Operating Cash Flow	6.84B
Capital Expenditures	-1.76B
Free Cash Flow	5.07B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 55.56%, with operating and profit margins of 17.87% and 31.95%.

Gross Margin	55.56%
Operating Margin	17.87%
Pretax Margin	16.72%
Profit Margin	31.95%
EBITDA Margin	25.54%
EBIT Margin	17.87%
FCF Margin	15.14%

Dividends & Yields

This stock pays an annual dividend of 1.77, which amounts to a dividend yield of 1.35%.

Dividend Per Share	1.77
Dividend Yield	1.35%
Dividend Growth (YoY)	7.32%
Years of Dividend Growth	6
Payout Ratio	28.62%
Buyback Yield	0.06%
Shareholder Yield	1.40%
Earnings Yield	6.08%
FCF Yield	2.89%

Dividend Details

Stock Splits

The last stock split was on June 1, 1998. It was a forward split with a ratio of 2.

Last Split Date	Jun 1, 1998
Split Type	Forward
Split Ratio	2

Scores

LON:0Q15 has an Altman Z-Score of 5.24.

Altman Z-Score	5.24
Piotroski F-Score	n/a